JP2018529345A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529345A5
JP2018529345A5 JP2018515528A JP2018515528A JP2018529345A5 JP 2018529345 A5 JP2018529345 A5 JP 2018529345A5 JP 2018515528 A JP2018515528 A JP 2018515528A JP 2018515528 A JP2018515528 A JP 2018515528A JP 2018529345 A5 JP2018529345 A5 JP 2018529345A5
Authority
JP
Japan
Prior art keywords
cells
seq
sample
mammal
cpg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018515528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018529345A (ja
Filing date
Publication date
Priority claimed from GBGB1516972.5A external-priority patent/GB201516972D0/en
Application filed filed Critical
Publication of JP2018529345A publication Critical patent/JP2018529345A/ja
Publication of JP2018529345A5 publication Critical patent/JP2018529345A5/ja
Pending legal-status Critical Current

Links

JP2018515528A 2015-09-25 2016-09-22 免疫細胞、特にb細胞の同定のためのエピジェネティックマーカーとしてのlrp5 Pending JP2018529345A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1516972.5A GB201516972D0 (en) 2015-09-25 2015-09-25 LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
GB1516972.5 2015-09-25
PCT/EP2016/072579 WO2017050916A1 (en) 2015-09-25 2016-09-22 Lrp5 as epigenetic marker for the identification of immune cells, in particular b-cells

Publications (2)

Publication Number Publication Date
JP2018529345A JP2018529345A (ja) 2018-10-11
JP2018529345A5 true JP2018529345A5 (cg-RX-API-DMAC10.html) 2019-10-31

Family

ID=54544102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018515528A Pending JP2018529345A (ja) 2015-09-25 2016-09-22 免疫細胞、特にb細胞の同定のためのエピジェネティックマーカーとしてのlrp5

Country Status (7)

Country Link
US (1) US11643687B2 (cg-RX-API-DMAC10.html)
EP (1) EP3353318B1 (cg-RX-API-DMAC10.html)
JP (1) JP2018529345A (cg-RX-API-DMAC10.html)
CN (1) CN108026578A (cg-RX-API-DMAC10.html)
GB (1) GB201516972D0 (cg-RX-API-DMAC10.html)
HK (1) HK1257122A1 (cg-RX-API-DMAC10.html)
WO (1) WO2017050916A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4403646A3 (en) * 2017-07-13 2025-01-08 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Dna targets as tissue-specific methylation markers
EP3778876A4 (en) * 2018-03-26 2022-01-12 Origincell Therapeutics Co., Ltd. METHOD OF PROMOTING IMMUNE CELL PROLIFERATION
DE102018112644B4 (de) * 2018-05-25 2020-06-10 Epiontis Gmbh CXCR3 als epigenetischer Marker zur Identifizierung von inflammatorischen Immunzellen, insbesondere CD8+ Gedächnis-T-Zellen
DE102018116353B4 (de) * 2018-07-05 2020-06-10 Epiontis Gmbh Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening
DE102020108560B4 (de) 2020-03-27 2022-03-03 Precision For Medicine Gmbh CBX6 als epigenetischer Marker für die Identifizierung von Immunzellen, insbesondere Gedächtnis-B-Zellen
CN119372296B (zh) * 2024-12-24 2025-06-13 北京致谱医学检验实验室有限公司 基于基因甲基化检测实现人b淋巴细胞计数的试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522600A (en) * 2000-05-26 2004-09-24 Genome Therapeutics Corp Regulating lipid levels via the Zmax1 or HBM gene
ATE508207T1 (de) * 2006-02-28 2011-05-15 Charite Universitaetsmedizin Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens
JP2011504462A (ja) * 2007-11-02 2011-02-10 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 腫瘍の予防および治療のための方法および化合物
US20110104695A1 (en) * 2009-11-05 2011-05-05 Epigenomics Ag Methods of predicting therapeutic efficacy of cancer therapy
EP2625288B1 (en) * 2010-10-08 2016-05-25 Epiontis GmbH Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes
US20130129668A1 (en) * 2011-09-01 2013-05-23 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
EP2986735B1 (en) * 2013-04-19 2019-03-06 Epiontis GmbH Method for identifying the quantitative composition of blood cells in a sample
CN106661618B (zh) 2014-05-30 2021-06-08 罗伯特·菲利伯特 Dna甲基化状态作为酒精使用和戒酒的生物标志物

Similar Documents

Publication Publication Date Title
Jara-Acevedo et al. Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications
Houseman et al. DNA methylation in whole blood: uses and challenges
Agnelli et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma
JP2012511917A5 (cg-RX-API-DMAC10.html)
EP3327141B1 (en) Method for identifying the quantitative cellular composition in a biological sample
JP2018529346A5 (cg-RX-API-DMAC10.html)
WO2007121276A3 (en) Enrichment of circulating fetal dna
JP2018534910A5 (cg-RX-API-DMAC10.html)
JP2022141905A (ja) 移植拒絶リスクを予測する新規の方法
Tomusiak et al. Development of a novel epigenetic clock resistant to changes in immune cell composition
HK1257122A1 (zh) Lrp5作为用於鉴定免疫细胞特别是b细胞的表观遗传标志物
Genshaft et al. Clinical implementation of single-cell RNA sequencing using liver fine needle aspirate tissue sampling and centralized processing captures compartment specific immuno-diversity
JP6113159B2 (ja) ナチュラルキラー細胞を同定するエピジェネティックマーカー
Brownlie et al. Distinct lung-homing receptor expression and activation profiles on NK cell and T cell subsets in COVID-19 and influenza
EP2625188A1 (en) Molecular determinant-based typing of kir alleles and kir-ligands
JP2021502806A5 (cg-RX-API-DMAC10.html)
CN105349641A (zh) 急性心肌梗死相关基因serpinb13及其应用
CN111575375A (zh) 一种多发性骨髓瘤基因突变检测试剂盒和检测方法
RU2715633C2 (ru) Способ идентификации в иммунном репертуаре cdr3 участков, ассоциированных с заболеваниями
JP2021502809A5 (cg-RX-API-DMAC10.html)
Blanc et al. Impact of a CD4 gene haplotype on the immune response in minipigs
Amato et al. Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal
WO2015052190A1 (en) Predicting increased risk for cancer
RU2706699C1 (ru) Способ прогнозирования неблагоприятного течения фиброза печени при хроническом гепатите С
Stirland et al. DNA Methylation as a Biomarker of Gestational SARS-CoV-2 Exposure: Differential Methylation Patterns in Placental and Cord Blood Tissues Model Third Trimester COVID-19